Sebi to act against pharma cos in case of non-disclosure of material information
Ajay Tyagi, Chairman, SEBI, was replying to questions pertaining to pharma companies
Author
Strides Shasun gets WHO pre-qualification for rectal artesunate product
Collaborates with Medicines for Malaria Venture and receives funding from Unitaid
India for formal recognition of traditional medicines in Singapore
Documents related to Ayurvedic and Siddha medicines have been submitted to the Singapore Health Authority
GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Doctors will analyse the trial results closely to assess whether GSK can indeed rewrite treatment standards by delivering a…
Cipla receives final approval for testosterone injection
Cypionate Injection is AO-rated generic therapeutic equivalent version of Pharmacia and Upjohn’s DepoTestosterone
Roche buys Foundation Medicine for $2.4 billion
The drugmaker first bought a 56 per cent stake in FMI for $1 billion in 2015
Cipla gets US FDA approval for Generic Sustiva
It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection…
Zydus Cadila gets US FDA nod for erectile dysfunction drug
The drug firm will be manufactured at its facility in Moraiya, Ahmedabad
US FDA approves first product from Glenmark’s US plant
The Monroe facility is Glenmark's first manufacturing site in the US, designed to manufacture a variety of fixed dose…
DRL launches Levetiracetam in Sodium Chloride Injection
The drug was launched in single-dose infusion bags in the US market
Dr Reddy’s Laboratories (DRL) has launched Levetiracetram in…